Get the Stockscreener App
16.34
1.43%
0.23
Abrdn Life Sciences Investors stock is traded at $16.34, with a volume of 184.50K.
It is up +1.43% in the last 24 hours and down -4.28% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
See More
Previous Close:
$16.11
Open:
$16.24
24h Volume:
184.50K
Relative Volume:
1.42
Market Cap:
$483.64M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.74%
1M Performance:
-4.28%
6M Performance:
+15.80%
1Y Performance:
+25.40%
1-Day Range:
$16.11
$16.40
1-Week Range:
$15.91
$16.80
52-Week Range:
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL vs DNP, UTG, ADX, UTF, GDV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.34 | 476.83M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.59 | 3.96B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
41.14 | 3.77B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
23.20 | 2.82B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
26.90 | 2.64B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
28.62 | 2.54B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
THQTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses - ADVFN Ltd
HQL PE Ratio & Valuation, Is HQL Overvalued - Intellectia AI
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - ADVFN Ltd
Layoff Watch: Will Abrdn Life Sciences Investors stock hit new highs in YEARDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 361.3% in February - Defense World
Sectors Review: Will Abrdn Life Sciences Investors stock hit new highs in YEAR2025 Growth vs Value & Comprehensive Market Scan Insights - baoquankhu1.vn
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
Abrdn Life Sciences Investors Fund Q4 2025 Commentary (HQL) - Seeking Alpha
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Aug Swings: Should I hold or sell Abrdn Healthcare Investors nowRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary - Seeking Alpha
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm (2026-02-23) - Seeking Alpha
What is Abrdn Life Sciences Investors s 5 year growth outlookWeekly Trend Report & Technical Pattern Based Signals - mfd.ru
Will Abrdn Life Sciences Investors benefit from rising consumer demandJuly 2025 Update & Verified Entry Point Signals - mfd.ru
Abrdn Healthcare Investors Fund Q4 2025 Commentary - Seeking Alpha
Aug Macro: Can THCH reach all time highs this yearQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-19) - Seeking Alpha
Abrdn Life Sciences Investors To Go Ex-Dividend On February 20th, 2026 With 0.56 USD Dividend Per Share - 富途牛牛
abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month HighTime to Buy? - MarketBeat
Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com Australia
Will Abrdn Life Sciences Investors stock recover after earningsTake Profit & Fast Moving Stock Watchlists - mfd.ru
Market Catalysts: How volatile is Abrdn Life Sciences Investors stockJuly 2025 Review & Fast Entry Momentum Alerts - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Decline in Short Interest - MarketBeat
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately (2026-02-14) - Seeking Alpha
Why Abrdn Life Sciences Investors stock is favored by top institutionsEarnings Beat & Community Shared Stock Ideas - mfd.ru
MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-14) - Seeking Alpha
Is Abrdn Healthcare Investors forming a double bottom2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Will Abrdn Healthcare Investors stock deliver long term returnsQuarterly Profit Review & Breakout Confirmation Trade Signals - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Should I add Abrdn Life Sciences Investors stock to my portfolio2025 Top Gainers & Weekly Breakout Watchlists - mfd.ru
Will Abrdn Healthcare Investors stock hit new highs in YEARStock Surge & Free Fast Entry Momentum Trade Alerts - mfd.ru
Should value investors consider Abrdn Healthcare InvestorsTrade Exit Report & Verified Momentum Stock Alerts - mfd.ru
What’s the outlook for Abrdn Life Sciences Investors’s sectorJuly 2025 Momentum & Stepwise Trade Signal Guides - mfd.ru
abrdn Healthcare Investors (NYSE:HQH) Sets New 52-Week HighShould You Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.56 Per Share - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) to Issue Dividend Increase$0.63 Per Share - MarketBeat
VIX Spike: What’s the outlook for Abrdn Life Sciences Investors’s sectorTreasury Yields & Verified Swing Trading Watchlists - mfd.ru
abrdn Healthcare Investors (HQH) Declares $0.63 Dividend - GuruFocus
Technical Analysis: Is ANTX stock a value trapJuly 2025 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Is Abrdn Life Sciences Investors benefiting from innovation trendsRate Hike & Smart Investment Allocation Insights - mfd.ru
Aug Sectors: Can Abrdn Life Sciences Investors sustain earnings growthQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - PR Newswire
Is Abrdn Life Sciences Investors currently under institutional pressureWeekly Stock Analysis & Safe Entry Trade Reports - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Trading 0.1% HigherTime to Buy? - MarketBeat
How Abrdn Healthcare Investors stock performs in weak economy2025 Institutional Moves & Technical Pattern Recognition Alerts - mfd.ru
Stock Market Recap: Can The Cigna Group grow without external fundingJuly 2025 PostEarnings & High Win Rate Trade Tips - baoquankhu1.vn
Penserra Capital Management LLC Purchases 159,618 Shares of abrdn Healthcare Investors $HQH - MarketBeat
Should I trade or invest in Abrdn Life Sciences Investors2025 Dividend Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year HighTime to Buy? - MarketBeat
Sectors Review: What is the dividend yield of NEOVBond Market & Fast Gain Stock Tips - baoquankhu1.vn
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.12%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):